# Clinical and Radiographic Evaluation of Pulpotomy Using Neoputty MTA Versus Pulpectomy Using Metapex in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis in Children Aged 4 to 9 Years.

> **NCT06929247** · NA · NOT_YET_RECRUITING · sponsor: **Mohamed Nashaat Mohamed** · enrollment: 70 (estimated)

## Conditions studied

- Pulpitis - Irreversible

## Interventions

- **PROCEDURE:** Pulpotomy using Neoputty Mineral Trioxide Aggregate
- **PROCEDURE:** single visit pulpectomy using metapex

## Key facts

- **NCT ID:** NCT06929247
- **Lead sponsor:** Mohamed Nashaat Mohamed
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04
- **Primary completion:** 2025-04
- **Final completion:** 2026-04
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06929247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06929247, "Clinical and Radiographic Evaluation of Pulpotomy Using Neoputty MTA Versus Pulpectomy Using Metapex in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis in Children Aged 4 to 9 Years.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06929247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*